STOCK TITAN

Arcadia Bioscien (RKDA) Stock News

RKDA Nasdaq

Welcome to our dedicated page for Arcadia Bioscien news (Ticker: RKDA), a resource for investors and traders seeking the latest updates and insights on Arcadia Bioscien stock.

Arcadia Biosciences, Inc. reports developments tied to its plant-based health and wellness products business, including Zola coconut water and agronomic wheat traits. Company news includes operating and financial results, business highlights, material agreements, shareholder voting matters, and capital-structure actions involving its publicly traded common stock.

Recurring updates also cover governance matters, security-structure disclosures, and other corporate events that affect the company's financing, reporting, and operating profile.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.71%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.74%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.75%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.05%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.59%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.02%
Tags
conferences earnings
-
Rhea-AI Summary

Arcadia Biosciences reported a remarkable 47% increase in total revenues for 2022, reaching $9.96 million, driven by strong sales of GoodWheat pasta and coconut water. Operating expenses declined by 32% to $28.8 million, significantly reducing cash burn. The launch of GoodWheat pasta exceeded expectations, distributing in over 1,200 stores within seven months. The company also unveiled Project Greenfield, a three-year plan to enhance profitability and product expansion. Despite the progress, net losses for the year increased to $15.4 million, highlighting ongoing challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.08%
Tags
-
Rhea-AI Summary

Arcadia Biosciences (Nasdaq: RKDA) will release its financial results for the fourth quarter and full year of 2022 on March 30, 2023, after market close. A conference call to discuss these results and key strategic achievements will take place at 4:30 p.m. ET (1:30 p.m. PT). Interested parties can access the call via an audio-only webcast on the Investors section of their website. Recorded replays will also be available post-call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
conferences earnings
Rhea-AI Summary

Arcadia Biosciences (Nasdaq: RKDA) announced a $6.0 million private placement of 666,334 shares of common stock at $9.00 per share, alongside Series A and Series B preferred investment options. The placement, expected to close by March 6, 2023, aims to fund Project Greenfield, a strategic plan designed to enhance profitability through expanding retail for products like GoodWheat™ high-fiber pasta and Zola coconut water. Additionally, the company will amend existing investment options to reduce their exercise price to $9.00 per share. An SEC registration statement for the resale of shares is targeted for filing by April 3, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23%
Tags
private placement

FAQ

What is the current stock price of Arcadia Bioscien (RKDA)?

The current stock price of Arcadia Bioscien (RKDA) is $1.07 as of June 12, 2026.

What is the market cap of Arcadia Bioscien (RKDA)?

The market cap of Arcadia Bioscien (RKDA) is approximately 2.2M.